STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

Why only for healthcare professionals?

The content on these information pages is directed solely at you if you are a doctor, nurse, or pharmacist, as it concerns treatment with prescription medicines.

Please confirm that you are a healthcare professional (healthcare assistant, nurse, doctor, psychologist, or other licensed healthcare professional).

Back to main page

Confirm and continue

Yazen participates in roundtable with Health Tech World

Exciting News from Yazen Health

We are thrilled to announce that Martin Carlsson, Associate Professor, Endocrinologist, Chief Medical Officer and founder of Yazen health, recently contributed to a dynamic roundtable debate hosted by Health Tech World.The discourse revolves around the current landscape and future trajectory of digital health. As pioneers in the field, we are proud to be at the forefront of this transformative journey.Digital health has already made significant strides, reshaping outcomes globally. For example; the NHS (UK) has added that digital delivery is crucial for the treatment of overweight and obesity in its NICE guidelines. Care via a digital platform is both more efficient and convenient for the patient which in turn leads to a better outcomes. Martin Carlsson, with his expertise and insights, explore how clinicians, innovators, and developers can further elevate success in 2024 and beyond.

Watch the roundtable on YouTube here: https://www.youtube.com/watch?v=HlDKFjkO87A

Start your weight loss journey with Yazen today

Everything you need to do is to create an account and answer some questions about your health

Get Started
Get Started
Get Started

More news

Press release
Yazen Health closes €19.5M series A to drive global growth

Yazen Health has successfully closed an oversubscribed €19.5 million series A funding round to fuel its international expansion. This investment enables Yazen to enhance its pioneering obesity treatment model, combining modern weight loss medication with comprehensive lifestyle support.

News
Sifted UK: Yazen raises €19.5m to expand obesity treatment in the EU

Yazen has secured €19.5 million in Series A funding to expand its GLP-1-based obesity treatment across Europe. The company combines medication with lifestyle support for sustainable weight loss results.

News
Lasker~DeBakey Award 2024 for groundbreaking GLP-1 obesity research

Lasker~DeBakey Award 2024 for groundbreaking GLP-1 obesity research